We are pleased to announce that Precordior Ltd. has been granted the ISO 13485:2016 quality certificate. ISO 13485:2016 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements. We are looking forward to bringing our […]
We are proud to announce that Precordior’s AF App for detecting atrial fibrillation is now formally a CE IIa Class Medical Device. Stay tuned for more news about the product launch and availability!
Precordior’s smartphone app for detection of atrial fibrillation has won the title of Finland’s Health Innovation of the Year at the Health Awards 2019 event in Helsinki, Finland. The 1st place award was received by Chairman Henri Klimscheffskij, CEO Juuso Blomster and Vice CEO Tuomas Valtonen. Health Award is a recognized award for the stars […]
Precordior was selected as a Top Innovator and granted the opportunity to pitch to an investor audience at Venture Summit West 2018 in Santa Clara, USA. CEO Tuomas Valtonen was honored to present the company’s business case to a wide audience of Venture Capital representatives and industry experts from the Silicon Valley region and beyond. […]
At Startup Day 2017 in Tartu, Estonia, Precordior was awarded the Champion’s Cup for Best Pitch of the Estonia-Finland Pitching Contest. Precordior’s pitch, delivered by CEO Tuomas Valtonen, described the company’s mobile app for detection of Atrial fibrillation (AFib), which has previously also received the award for Best Smart Solution for Healthtech at the University […]
At the University Startup World Cup 2017, Precordior’s mobile app for detection of Atrial fibrillation received the award for Best Smart Solution for Healthtech. CEO Tuomas Valtonen represented Precordior at USWC this year: “We are delighted to receive recognition in a worldwide competition for our efforts towards detecting AFib and reducing strokes worldwide. We have […]
Precordior Ltd. has been selected as a finalist at the University Startup World Cup 2017, taking place on September 18-22 in Copenhagen, Denmark. The University Startup World Cup organising committee has invited the 70+ best startups worldwide from more than 40 countries to participate in the Copenhagen final, with a grand prize of $25,000. […]
Precordior is opening its Turku office on June 1, in the PharmaCity building near Kupittaa railway station. You can find us in the Werstas premises of PharmaCity, 2nd floor, suite 2040. We are looking forward to meeting you!
We are pleased to announce the Precordior is now an official registered trademark in Europe, with international registration pending. Hence, we are now proud to accompany our company logo with the (R) symbol.
We are delighted to announce that after five intense years of academic research and technical R&D in the field of cardiac monitoring, our company Precordior Ltd. is now up and running as of December 16, 2016. We wish to thank the University of Turku, Turku University Hospital, the Finnish Funding Agency for Innovation (Tekes) and […]